Frequent aberration of the transforming growth factor-β receptor II gene in cell lines but no apparent mutation in pre-invasive and invasive carcinomas of the uterine cervix

International Journal of Cancer

Volumn 80, Issue 4, 1999, Pages 506-510

  Chu, Tang Yuan ^a,b   Lai, Jen Shuen ^a   Shen, Chen Yang ^c   Liu, Hang Seng ^a   Chao, Chung Faye ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c Sec 3 ^*

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CANCER INVASION; CHROMOSOME 3P; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

CARCINOMA, SQUAMOUS CELL; FEMALE; GENE DELETION; HELA CELLS; HUMANS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0033521859     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990209)80:4<506::AID-IJC4>3.0.CO;2-E     Document Type: Article

References (37)

1. BASCOM, C.C., WOLFSHOHL, J.R., COFFEY, R.J., JR. MADISEN, L., WEBB, N.R., PURCHIO, A.R., DERYNCK, R. and MOSES, H.L., Complex regulation of transforming growth factor β1, β2, and β3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors β1 and β2. Mol. cell. Biol. 9, 5508-5515 (1989).
2. BRAUN, L., DURST, M., MIKUMO, R., CROWLEY, A. and ROBINSON, M., Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor β: implications tor the control of papillomavirus infection. Mol. Carcinogen., 6, 100-111 (1992).
3. BRAUN, L., DURST, R., MIKUMO, R. and GRUPPUSO, P., Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor β1. Cancer Res., 50, 7324-7332 (1990).
4. CHU, T.Y., SHEN, C.Y., CHIOU, Y.S., LU, J.J., PERNG, C.L., YU, M.S. and LU, H.S., HPV associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA. Int. J. Cancer, 75, 199-204 (1998a).
5. CHU, T.Y., SHEN, C.Y., LEE, H.S., LAI, C.H. and LIU, H.S., Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution. Genes Chromosomes Cancer (1998b). (In press).
6. COMERCI, J.T., RUNOWICZ, C.D., FLANDERS, K.C., VICTORIA, C.D., FIELDS, A.L., KADISH, A.S. and GOLDBERG, G.L., Altered expression of transforming growth factor-β1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix. Cancer, 77, 1107-1114 (1996).
7. DYSON, N., HOWLEY, P.M., MUNGER, K. and HARLOW, E., The human papillomavirus 16E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 243, 934-937 (1989).
8. GARRIGUE-ANTAR, L., MUUNOZ-ANTONIA, T., ANTONIA, S.J., GESMONDE, J., VELLUCCI, V.F. and REISS, M., Missense mutation of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55, 3982-3987 (1995).
9. 1 arrest, p53, and Rb. Cancer Res., 56, 3645-3650 (1996).
10. HURLIN, P.J., KAUR, P., SMITH, P.P., PEREZ, R.N., BLANTON, R.A. and MCDOUGALL, J.K., Progression of human papillomavirus type 18 immortalized human keratinocytes to a malignant phenotype. Proc. nat. Acad. Sci. (Wash.), 88, 570-574 (1991).
11. KERSEMAEKERS, A.M., HERMANS, J., FLEUREN, G.J. and VAN DE VUVER, M.J., Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Brit. J. Cancer, 77, 192-200 (1998).
12. KIVIAT, N., Natural history of cervical neoplasia: overview and update. Amer. J. Obstet. Gynecol., 175, 1099-1104 (1996).
13. KU, W.H., LIU, I.L., YEN, M.S., CHANG-CHIN, C.C., YUE, C.T., MA, Y.Y., CHANG, S.F., NG, H.T., WU, C.W. and SHEN, C.Y., Genomic deletion and p53 inactivation in cervical carcinoma. Int. J. Cancer, 72, 270-276 (1997).
14. LARSON, A.A., KERN, S., CURTISS, S., GORDON, R., CAVENEE, W.K. and HAMPTON, G.M., High resolution analysis of chromosome 3p alterations in cervical carcinoma. Cancer Res., 57, 4082-4090 (1997).
15. LOEB, L.A., Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 51, 3075-3079 (1991).
16. LU, S.L., ZHANG, W.C., AKIYAMA, Y., NOMIZU, T. and YUASA, Y., Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers. Cancer Res., 56, 4595-1598 (1996).
17. MARKOWITZ, S., WANG, J., MYEROFF, L., PARSON, R., SUN, L., LUTTERBAUGH, J., FAN, R., ZBOROWSKA, E., KINZLER, K.W., VOGELSTEIN, B., BRATTAIN, M. and WILLDON, J.K., Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 268, 1336-1338 (1995).
18. MASSAGUE, J., The transforming growth factor-β family. Ann. Rev. Cell Biol., 6, 597-641 (1990).
19. MATHEW, S., MURTY, V.V., CHEIFEITZ, S., GEORGE, D., MASSAGIE, J. and CHAGANTI, R.S., Transforming growth factor receptor gene TGFBR2 maps to human chromosome band 3p22. Genomics, 20, 114-115 (1994).
20. MITRA, A.B., MURTY, V.V.V.S., LI, R.G., PRATAP, M., LUTHRA, U.K. and CHAGANTI, R.S.K., Allelotype analysis of cervical cancer. Cancer Res., 54, 4481-4487 (1994).
21. MITRA, A.B., MURTY, V.V.V.S., SINGH, V., LI, R.G., PRATAP, M., SODHANI, P., LUTHRA, U.K. and CHAGANTI, R.S.K., Genetic alterations at 5p15: a potential marker for progression of precancerous lesions of the uterine cervix. J. nat. Cancer Inst. 87, 742-745 (1995).
22. MOSES, H., YANG, E. and PIETENPOL, J., TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell. 63, 245-247 (1990).
23. MULLOKANDOV, M.R., KHOLODILOV, N.G., ATKIN, N.B., BURK, R.D., JOHNSON, A.B. and KLINGER, H.P., Genomic alterations in cervical carcinoma: loss of chromosome heterozygosity and human papillomavirus tumor status. Cancer Res., 36, 197-205 (1996).
24. MUNOZ, N., BOSCH, X., SHAH, K.V. and MEHEUS, A. (eds.). International Agency for Research on Cancer (WHO). The epidemiology of human papillomavirus and cervical cancer. IARC Scientific Publication 119, IARC, Lyon (1992).
25. MYEROFF, L.L. and 16 OTHERS, Transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55, 5545-5547 (1995).
26. OTO, M., MIYAKE, S. and YUASA, Y., Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional minislab gel electrophoresis apparatus. Anal. Biochem., 213, 19-22 (1993).
27. PARK, K., KIM, S.J., BANG, Y.J., PARK, J.G., KIM, N.K., ROBERTS, A.B. and SPORN, M.B., Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. nat. Acad. Sci. (Wash.), 91, 8772-8776 (1994).
28. PARSON, R., MYEROFF, L.L., LIU, B., WILLSON, J.K.V., MARKOWITA, S.D., KINZLER, K.W. and VOGELSTEIN, B., Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res., 55, 5548-5550 (1995).
29. PHELPS, W.C., YEE, C.L., MUNGER, K. and HOWLEY, P.M., The human papillomavirus type E7 gene encodes transactivation and transformation functions similar to adenovirus Ela. Cell. 53, 539-547 (1988).
30. SHIPELY, G.D., PITTELKOW, M.R., WILLE, J.J., SCOTT, R.E. and MOSS, H.L., Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor inhibition in serum free medium. Cancer Res., 46, 2068-2071 (1986).
31. TURNER, M.A., DARRAGH, T. and PALEFSKY, J.M., Epithelial-stromal interactions modulating penetration of matrigel membranes by HPV-16 immortalized keratinocytes. J. invest. Dermatol., 109, 619-625 (1997).
32. VINCENT, F., HAGIWARA, K., KE, Y., STONER, G.D., DEMETRICK, D.J. and BENNETT, W.P., Mutation analysis of the transforming growth factor β in sporadic human cancers of the pancreas, liver, and breast. Biochem. biophys. Res. Commun., 223, 561-564 (1996).
33. VINCENT, F., NAGASHIMA, M., TAKENOSHITA, S., KHAN, M.A., GEMMA, A., HAGIWARA, K. and BENNETT, W.P., Mutation analysis of the transforming growth factor-β type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-β. Oncogene, 15, 117-122 (1997).
34. WIESER, R., ATTISANO, L., WRANA, J.L. and MASSAGUE, J., Signaling activity of transforming growth factor β type II receptors lacking specific domains in the cytoplasmic region. Mol. cell. Biol. 13, 7239-7247 (1993).
35. WISTUBA, I.I., MONTELLANO, F.D., MILCHGRUB, S., VIRMANI, A.K., BEHRENS, C. CHEN, H., AHMADIAN, M., NOWAK, J.A., MULLER, C., MINNA, J.D. and GAZDAR, A.F., Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res., 57, 3154-3158 (1997).
36. WRANA, J.L., ATTISANO, L., CARCAMO, J., ZENTELLA, A., DOODY, J., LAIHO, M., WANG, X.F. and MASSAGUE, J., TGF β signals through a heteromeric protein kinase receptor complex. Cell, 71, 1003-1014 (1992).
37. YOKOTA, J., TSUKADA, Y., NAKAJIMA, T., GOTOH, M., SHIMOSATO, Y., MORI, N., TSUNOKAWA, Y., SUGIMURA, T. and TERADA, M., Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res., 49, 3598-3601 (1989).